We have located links that may give you full text access.
MTHFR rs1801133 polymorphism and susceptibility to colorectal cancer in Iranian population: evidence of a case-control study and meta-analysis.
Pharmacogenomics 2016 October 29
Several studies have investigated whether MTHFR rs1801133 polymorphism contributes to risk of colorectal cancer (CRC), however the results are inconclusive.
AIM: The purpose of this study was to investigate this hypothesis in a case-control study and meta-analysis in Iranian population.
MATERIALS & METHODS: This polymorphism was genotyped in the 2421 subjects (46% CRC patients) from Tehran. Meta-analysis was performed for determining the risk effect size of this polymorphism on CRC.
RESULTS: Both case-control study and meta-analysis showed no association between rs1801133 and CRC risk or its features.
CONCLUSION: This study failed to identify an association between the rs1801133 and susceptibility to CRC in Iranian population.
AIM: The purpose of this study was to investigate this hypothesis in a case-control study and meta-analysis in Iranian population.
MATERIALS & METHODS: This polymorphism was genotyped in the 2421 subjects (46% CRC patients) from Tehran. Meta-analysis was performed for determining the risk effect size of this polymorphism on CRC.
RESULTS: Both case-control study and meta-analysis showed no association between rs1801133 and CRC risk or its features.
CONCLUSION: This study failed to identify an association between the rs1801133 and susceptibility to CRC in Iranian population.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app